A stent is one of the most common procedures in cardiology, and most of the time, it isn't placed during a heart attack at all. It's placed calmly, electively, after a blockage is found through testing, well before anything becomes an emergency.
That's genuinely good news. But there's a part of the story that rarely gets explained clearly: a stent fixes a blockage. It doesn't fix the disease that caused it.
High Lp(a) and a History of a Stent?
A Phase 3 study is currently enrolling adults with elevated Lp(a) and documented coronary artery disease.
Most Stents Are Never About an Emergency
It's easy to assume a stent means someone survived a heart attack, but that's true for a minority of cases. Registry data consistently show that roughly 85% of all stent procedures in the US are done electively, for stable angina, meaning chest pain that shows up predictably during exertion, not during an emergency. Over a million coronary stent procedures happen in the US each year, and most of them look like a blockage found through testing, addressed calmly and directly, no ambulance involved.
That's genuinely good news in one sense. Finding and treating a blockage before it causes a heart attack is exactly the kind of outcome cardiology aims for. But it also means a very large group of people walk out of the hospital with a diagnosis of coronary artery disease and very little discussion of what that diagnosis means going forward.
What the Stent Actually Did, and Didn't Do
A stent is a mechanical fix for a specific problem: a narrowed section of artery. It restores blood flow through that segment, and for stable angina, it's genuinely effective at relieving the chest pain or breathlessness that sent you in for testing in the first place.
Here's the part that gets less airtime: for stable coronary artery disease, major trials, including a large one called ISCHEMIA, have found that adding a stent on top of good medical therapy doesn't extend life or reduce heart attack risk compared to medication and risk factor management alone, in most stable patients. Stenting treats the blockage it can see. It doesn't treat the broader disease process, atherosclerosis, that produced it and that's still active throughout the rest of your arteries.
There's also a practical follow-up question worth knowing about: the treated segment itself can re-narrow over time, a process called restenosis, which happens in roughly 1 in 10 stent patients. When it happens, it isn't always gradual or symptom-free. In a meaningful share of cases, it shows up as an acute event rather than a slow return of the old chest pain.
None of this is meant to alarm you. It's meant to correct a common, understandable assumption: that a successful procedure means the underlying story is over.
Why the Underlying Condition Still Matters
Here's the part that matters most: having documented coronary artery disease, confirmed by the same imaging that led to your stent, puts you in largely the same long-term risk category as someone who's had an actual heart attack, even though your path to that diagnosis looked different. The blockage that was found and treated is evidence that atherosclerosis, plaque buildup in your arteries, is already an active process in your body, not a future possibility. That's exactly why ongoing risk management still matters.
A Test Worth Asking About
After a stent, standard care usually includes a statin, medication to prevent clotting, and attention to your blood pressure and blood sugar. One thing it usually doesn't include is a test for lipoprotein(a), or Lp(a).
Lp(a) is a cholesterol-carrying particle in your blood. Unlike LDL cholesterol, it's set almost entirely by your genes, doesn't respond to statins, and isn't part of a routine cholesterol test. About 1 in 5 people worldwide has an elevated level of Lp(a).
Blood pressure, blood sugar, smoking, and LDL cholesterol all play a role in narrowed arteries too, so Lp(a) isn't the only piece of the puzzle. But it's one of the few that a standard checkup won't catch, which makes it worth knowing about once you already have a confirmed diagnosis. It only takes one blood draw, and since the level stays the same throughout your life, you typically only need to check it once.
What's Changing in Treatment
There's no medication approved yet that directly lowers Lp(a), so today's approach still centers on managing everything else aggressively, the same medications and habits your care team likely already discussed with you. That's starting to change: several Lp(a)-targeted drugs, including options from Eli Lilly, are now in late-stage clinical trials.
One of them, muvalaplin, an oral medication, is being tested in a Phase 3 study for adults with elevated Lp(a) and documented coronary artery disease, which specifically includes people who've had a procedure like a stent, whether or not they ever had a heart attack itself. The study page has the full eligibility details and current recruiting locations.
The Bottom Line
A stent for stable angina is a genuine success story: a problem was found early and treated before it became a crisis. But "treated" isn't the same as "resolved." The disease that produced the blockage is still part of your cardiovascular picture. That's exactly why paying attention to risk factors, and asking about a test like Lp(a), is still worth doing.
Frequently Asked Questions
If I had a stent but not a heart attack, do I still have heart disease? Yes. A stent is placed because imaging confirmed a blockage from atherosclerosis, the same disease process behind a heart attack. The diagnosis is coronary artery disease, regardless of how it was found.
Does a stent fix the underlying problem? It restores blood flow through the treated section and relieves symptoms, but it doesn't stop the broader disease process elsewhere in your arteries. Ongoing risk factor management remains important afterward.
Will I need another stent? Most people don't, but the treated area can re-narrow (restenosis) in roughly 1 in 10 cases. Regular follow-up with your cardiologist is the way this gets caught early.
What is Lp(a), and why does it matter after a stent? Lp(a) is a genetically determined, cholesterol-carrying particle that contributes to plaque buildup independently of LDL cholesterol. It isn't part of routine bloodwork and doesn't respond to statins, which is why it's easy to miss even after a cardiac diagnosis.
Can I lower my Lp(a) with diet or exercise? Not meaningfully. It's set almost entirely by genetics. Lifestyle changes still matter a great deal for the overall risk that number translates into.
Is there a treatment for high Lp(a) yet? Not one approved specifically for lowering it. Current care focuses on managing every other modifiable risk factor. Several Lp(a)-lowering drugs are currently in late-stage clinical trials.